E. P. Rhee, R. E. Gerszten, C. Metabolomics, and . Biomarker-discovery, Clinical Chemistry, vol.58, pp.139-147, 2012.

G. Van-camp, Cardiovascular disease prevention, Acta Clin Belg, vol.69, pp.407-411, 2014.

D. Giavarina, E. Barzon, M. Cigolini, G. Mezzena, and G. Soffiati, Comparison of methods to identify individuals at increased risk of cardiovascular disease in Italian cohorts, Nutr Metab Cardiovasc Dis, vol.17, pp.311-318, 2007.

C. Nishida, R. Uauy, S. Kumanyika, and P. Shetty, The joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications, Public Health Nutr, vol.7, pp.245-250, 2004.

W. B. Kannel, Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study, American Heart Journal, vol.110, pp.1100-1107, 1985.

S. Hamada and M. C. Gulliford, Multiple risk factor control, mortality and cardiovascular events in type 2 diabetes and chronic kidney disease: a population-based cohort study, BMJ Open, vol.8, p.19950, 2018.

N. Chalasani, The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases, Hepatology, vol.67, pp.328-357, 2018.

M. E. Rinella, Nonalcoholic fatty liver disease: a systematic review, JAMA, vol.313, pp.2263-2273, 2015.

Z. Wang, Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease, Nature, vol.472, pp.57-63, 2011.

Z. Wang, W. H. Tang, L. Cho, D. M. Brennan, and S. L. Hazen, Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition, Arterioscler. Thromb. Vasc. Biol, vol.29, pp.1383-1391, 2009.

J. F. Mann, H. C. Gerstein, J. Pogue, J. Bosch, and S. Yusuf, Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial, Ann. Intern. Med, vol.134, pp.629-636, 2001.

C. Blanchard, Roux-en-Y gastric bypass reduces plasma cholesterol in diet-induced obese mice by affecting trans-intestinal cholesterol excretion and intestinal cholesterol absorption, Int J Obes (Lond), vol.42, pp.552-560, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01833321

E. Jokinen, Obesity and cardiovascular disease, Minerva Pediatr, vol.67, pp.25-32, 2015.

A. Rawshani, Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes, N. Engl. J. Med, vol.379, pp.633-644, 2018.

L. Darryl and P. , Reducing the Global Burden of Cardiovascular Disease, Part 2, Circulation Research, vol.121, pp.695-710, 2017.

E. Yu, Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study, The Journal of Clinical Endocrinology & Metabolism, vol.102, pp.1879-1888, 2017.

T. Münzel, T. Gori, J. F. Keaney, C. Maack, and A. Daiber, Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications, Eur. Heart J, vol.36, pp.2555-2564, 2015.

S. S. Lim, A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study, Lancet, vol.380, pp.2224-2260, 2010.

A. Daiber, New Therapeutic Implications of Endothelial Nitric Oxide Synthase (eNOS) Function/Dysfunction in Cardiovascular Disease, Int J Mol Sci, vol.20, 2019.

T. Münzel, Effects of gaseous and solid constituents of air pollution on endothelial function, Eur. Heart J, vol.39, pp.3543-3550, 2018.

T. Münzel, Environmental Noise and the Cardiovascular System, J. Am. Coll. Cardiol, vol.71, pp.688-697, 2018.

A. Rosengren, Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study, Lancet, vol.364, pp.953-962, 2004.

S. Yusuf, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, Lancet, vol.364, pp.937-952, 2004.

H. Zhang, Artery interposed to vein did not develop atherosclerosis and underwent atrophic remodeling in cholesterol-fed rabbits, Atherosclerosis, vol.177, pp.37-41, 2004.

G. Choi-byoung, Association of Major Adverse Cardiac Events up to 5 Years in Patients With Chest Pain Without Significant Coronary Artery Disease in the Korean Population, Journal of the American Heart Association, vol.8, p.10541, 2019.

. Null-null, Guideline Update for the Management of Patients With Chronic Stable Angina-Summary Article, Circulation, vol.107, pp.149-158, 2002.

H. Yasue, H. Nakagawa, T. Itoh, E. Harada, and Y. Mizuno, Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment, J Cardiol, vol.51, pp.2-17, 2008.

P. Nam, The impact of myocardial bridge on coronary artery spasm and long-term clinical outcomes in patients without significant atherosclerotic stenosis, Atherosclerosis, vol.270, pp.8-12, 2018.

B. G. Choi, Three-year follow-up of patients with acetylcholine-induced coronary artery spasm combined with insignificant coronary stenosis, Int. J. Cardiol, vol.238, pp.66-71, 2017.

O. Peter, Clinical Usefulness, Angiographic Characteristics, and Safety Evaluation of Intracoronary Acetylcholine Provocation Testing Among 921 Consecutive White Patients With Unobstructed Coronary Arteries, Circulation, vol.129, pp.1723-1730, 2014.

M. Lassalle, C. Ayav, L. Frimat, C. Jacquelinet, and C. Couchoud, The essential of 2012 results from the French Renal Epidemiology and Information Network (REIN) ESRD registry, Néphrologie & Thérapeutique, vol.11, pp.78-87, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01816064

, Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death, New England Journal of Medicine, vol.364, pp.829-841, 2011.

D. Sun, Type 2 Diabetes and Hypertension: A Study on Bidirectional Causality, Circ. Res, 2019.

R. Roussel, P. G. Steg, K. Mohammedi, M. Marre, and L. Potier, Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering interventions, Diabetes Obes Metab, vol.20, pp.238-244, 2018.

J. Stamler, O. Vaccaro, J. D. Neaton, and D. Wentworth, Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial, Diabetes Care, vol.16, pp.434-444, 1993.

M. C. Al, Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women f

A. S. Levey, National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Ann. Intern. Med, vol.139, pp.137-147, 2003.

, National High Blood Pressure Education Program. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. (National Heart, Lung, and Blood Institute, 2004.

A. Hakeem, Renal function and risk stratification of diabetic and nondiabetic patients undergoing evaluation for coronary artery disease, JACC Cardiovasc Imaging, vol.3, pp.734-745, 2010.

, National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am. J. Kidney Dis, vol.39, pp.1-266, 2002.

J. Coresh, B. C. Astor, T. Greene, G. Eknoyan, and A. S. Levey, Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey, Am. J. Kidney Dis, vol.41, pp.1-12, 2003.

D. Murphy, Trends in prevalence of chronic kidney disease in the United States, Ann Intern Med, vol.165, pp.473-481, 2016.

J. Halimi, The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients, Diabetes & Metabolism, vol.38, pp.291-297, 2012.

E. J. Weil, Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy, Kidney International, vol.82, pp.1010-1017, 2012.

C. M. Hales, Prevalence of Obesity Among Adults and Youth: United States, 2015.

C. Cadenas-sanchez, Prevalence of overweight/obesity and fitness level in preschool children from the north compared with the south of Europe: an exploration with two countries, Pediatric Obesity, vol.11, pp.403-410, 2016.

D. K. Sanghera, C. Bejar, S. Sharma, R. Gupta, and P. R. Blackett, Obesity Genetics and Cardiometabolic Health: Potential for Risk Prediction, Diabetes Obes Metab, 2019.

T. Mandviwala, U. Khalid, and A. Deswal, Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?, Curr Atheroscler Rep, vol.18, p.21, 2016.

P. Poirier and J. Després, Obésité et maladies cardiovasculaires, Med Sci, vol.19, pp.943-949, 2003.

K. Penny, E. Robert, H. , H. Barbara, and V. St, Jeor Sachiko & Bazzarre Terry L. Lyon Diet Heart Study, Circulation, vol.103, pp.1823-1825, 2001.

R. M. Parikh and V. Mohan, Changing definitions of metabolic syndrome, Indian J Endocrinol Metab, vol.16, pp.7-12, 2012.

, Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), Expert Panel on Detection, vol.285, pp.2486-2497, 2001.

H. Buchwald, The Evolution of Metabolic/Bariatric Surgery, OBES SURG, vol.24, pp.1126-1135, 2014.

, Prise en charge chirurgicale de l'obésité chez l'adulte : les différentes techniques, Haute Autorité de Santé

C. Blanchard, Roux-en-Y gastric bypass reduces plasma cholesterol in diet-induced obese mice by affecting trans-intestinal cholesterol excretion and intestinal cholesterol absorption, Int J Obes (Lond), vol.42, pp.552-560, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01833321

F. H. Karlsson, Symptomatic atherosclerosis is associated with an altered gut metagenome, Nature Communications, vol.3, 2012.

X. S. Li, Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors, European Heart Journal, vol.582, 2017.

S. H. Zeisel, M. Warrier, . Trimethylamine-n--oxide, H. The-microbiome, and K. Disease, Annual Review of Nutrition, vol.37, pp.157-181, 2017.

W. H. Tang, Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk, N Engl J Med, vol.368, pp.1575-1584, 2013.

M. H. Janeiro, M. J. Ramírez, F. I. Milagro, J. A. Martínez, and M. Solas, Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target, Nutrients, vol.10, 2018.

D. Fennema, I. R. Phillips, E. A. Shephard, . Trimethylamine, and N. Trimethylamine, Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease, Drug Metab. Dispos, vol.44, pp.1839-1850, 2016.

Y. Zhu, Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota, Proc. Natl. Acad. Sci. U.S.A, vol.111, pp.4268-4273, 2014.

N. Longo, M. Frigeni, M. Pasquali, . Carnitine, . Fatty et al., Biochim Biophys Acta, vol.1863, pp.2422-2435, 2016.

Y. Chen, N. A. Patel, A. Crombie, J. H. Scrivens, and J. C. Murrell, Bacterial flavincontaining monooxygenase is trimethylamine monooxygenase, Proc. Natl. Acad. Sci. U.S.A, vol.108, pp.17791-17796, 2011.

J. Chhibber-goel, The complex metabolism of trimethylamine in humans: endogenous and exogenous sources, Expert Rev Mol Med, vol.18, p.8, 2016.

B. J. Bennett, Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation, Cell Metab, vol.17, pp.49-60, 2013.

T. Esposito, B. Varriale, R. D'angelo, A. Amato, and A. Sidoti, Regulation of flavincontaining mono-oxygenase (Fmo3) gene expression by steroids in mice and humans, Horm Mol Biol Clin Investig, vol.20, pp.99-109, 2014.

Z. Wang, Prognostic value of choline and betaine depends on intestinal microbiotagenerated metabolite trimethylamine-N-oxide, Eur. Heart J, vol.35, pp.904-910, 2014.

M. Canyelles, Trimethylamine N-Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function, Int J Mol Sci, vol.19, 2018.

G. Charach, A. Rabinovich, O. Argov, M. Weintraub, and P. Rabinovich, The role of bile Acid excretion in atherosclerotic coronary artery disease, Int J Vasc Med, vol.2012, p.949672, 2012.

R. A. Koeth, Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis, Nat Med, vol.19, pp.576-585, 2013.

M. Makishima, Identification of a nuclear receptor for bile acids, Science, vol.284, pp.1362-1365, 1999.

G. G. Hov, K. I. Aasarød, E. Sagen, and A. Åsberg, Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease, Clinical Biochemistry, vol.48, pp.646-651, 2015.

S. Moncada and A. Higgs, The L-arginine-nitric oxide pathway, N. Engl. J. Med, vol.329, pp.2002-2012, 1993.

D. Gangi and I. M. , Simultaneous quantitative determination of NG,NG-dimethyl-l-arginine or asymmetric dimethylarginine and related pathway's metabolites in biological fluids by ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry, Analytica Chimica Acta, vol.677, pp.140-148, 2010.

D. Tsikas, A. Bollenbach, E. Hanff, and A. A. Kayacelebi, Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes, Cardiovascular Diabetology, vol.17, 2018.

J. Rysz, A. Gluba-brzózka, B. Franczyk, Z. Jab?onowski, and A. Cia?kowska-rysz, Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome, Int J Mol Sci, vol.18, 2017.

C. Rasmusen, L. Cynober, and R. Couderc, Arginine et statines : relation avec le métabolisme du monoxyde d'azote et perspectives dans le traitement de l'athérosclérose, Annales de Biologie Clinique, vol.63, pp.443-455, 2005.

R. H. Böger, Association of asymmetric dimethylarginine and endothelial dysfunction, Clin. Chem. Lab. Med, vol.41, pp.1467-1472, 2003.

D. E. Wilcken, A. S. Sim, J. Wang, and X. L. Wang, Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of l-arginine on its metabolism, Molecular Genetics and Metabolism, vol.91, pp.309-317, 2007.

V. Patrick and &. James, Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, pp.1023-1030, 2004.

T. Teerlink, ADMA metabolism and clearance, Vasc Med, vol.10, pp.73-81, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00571350

R. Plumb, Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry, Rapid Commun. Mass Spectrom, vol.18, pp.2331-2337, 2004.

J. Nawrocki, C. Dunlap, A. Mccormick, P. W. Carr, and I. Part, Chromatography using ultrastable metal oxide-based stationary phases for HPLC, J Chromatogr A, vol.1028, pp.1-30, 2004.

A. R. Johnson and M. F. Vitha, Chromatographic selectivity triangles, Journal of Chromatography A, vol.1218, pp.556-586, 2011.

C. F. Poole and N. Lenca, Applications of the solvation parameter model in reversed-phase liquid chromatography, Journal of Chromatography A, vol.1486, pp.2-19, 2017.

L. R. Snyder, J. J. Kirkland, and J. L. Glajch, Practical HPLC Method Development, 2012.

D. V. Mccalley, Understanding and manipulating the separation in hydrophilic interaction liquid chromatography, J Chromatogr A, vol.1523, pp.49-71, 2017.

A. J. Alpert, Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds, J. Chromatogr, vol.499, pp.177-196, 1990.

B. Buszewski and S. Noga, Hydrophilic interaction liquid chromatography (HILIC)--a powerful separation technique, Anal Bioanal Chem, vol.402, pp.231-247, 2012.

X. Subirats, E. Bosch, and M. Rosés, Retention of ionisable compounds on high-performance liquid chromatography XVIII: pH variation in mobile phases containing formic acid, piperazine, tris, boric acid or carbonate as buffering systems and acetonitrile as organic modifier, J Chromatogr A, vol.1216, pp.2491-2498, 2009.

W. J. Griffiths, A. P. Jonsson, S. Liu, D. K. Rai, and Y. Wang, Electrospray and tandem mass spectrometry in biochemistry, Biochem. J, vol.355, pp.545-561, 2001.

M. Karas and F. Hillenkamp, Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons, Anal. Chem, vol.60, pp.2299-2301, 1988.

M. Yamashita and J. B. Fenn, Electrospray ion source. Another variation on the free-jet theme, J. Phys. Chem, vol.88, pp.4451-4459, 1984.

M. Yamashita and J. B. Fenn, Negative ion production with the electrospray ion source, J. Phys. Chem, vol.88, pp.4671-4675, 1984.

J. B. Fenn, M. Mann, C. K. Meng, S. F. Wong, and C. M. Whitehouse, Electrospray ionization for mass spectrometry of large biomolecules, Science, vol.246, pp.64-71, 1989.

A. A. Rostom and C. V. Robinson, Detection of the Intact GroEL Chaperonin Assembly by Mass Spectrometry, J. Am. Chem. Soc, vol.121, pp.4718-4719, 1999.

M. A. Tito, K. Tars, K. Valegard, J. Hajdu, and C. V. Robinson, Electrospray Time-of-Flight Mass Spectrometry of the Intact MS2 Virus Capsid, J. Am. Chem. Soc, vol.122, pp.3550-3551, 2000.

T. Ingram, Disintegration of water drops in an electric field, Proceedings of the Royal Society of London. Series A. Mathematical and Physical Sciences, vol.280, pp.383-397, 1964.

E. Werner, Analyse du métabolome par chromatographie liquide couplée à la spectrométrie de masse : application à la recherche de biomarqueurs indirects d'induction enzymatique, 2011.

J. E. Campana, Elementary theory of the quadrupole mass filter, International Journal of Mass Spectrometry and Ion Physics, vol.33, pp.101-117, 1980.

P. Dubreuil,

V. Hibou, M. S. Spectrométrie-de-masse-en-tandem, and . Ms, Analytical Toxicology. Analytical Toxicology, 2017.

S. Hadjadj, Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabetes Care, vol.31, pp.1847-1852, 2008.

A. S. Levey, A new equation to estimate glomerular filtration rate, Ann. Intern. Med, vol.150, pp.604-612, 2009.

P. E. Khoury, Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes, Diabetes, Obesity and Metabolism, vol.20, pp.943-953, 2018.

K. D. Wyndham, Characterization and evaluation of C18 HPLC stationary phases based on ethyl-bridged hybrid organic/inorganic particles, Anal. Chem, vol.75, pp.6781-6788, 2003.

S. Mi, Y. Zhao, R. L. Jacobs, and J. M. Curtis, Simultaneous determination of trimethylamine and trimethylamine N-oxide in mouse plasma samples by hydrophilic interaction liquid chromatography coupled to tandem mass spectrometry, Journal of Separation Science, vol.40, pp.688-696, 2017.

N. R. Cook and N. P. Paynter, Performance of Reclassification Statistics in Comparing Risk Prediction Models, Biom J, vol.53, pp.237-258, 2011.

A. J. Hayes, J. Leal, A. M. Gray, R. R. Holman, and P. M. Clarke, UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82, Diabetologia, vol.56, pp.1925-1933, 2013.

P. Saulnier, Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective Cohort, Diabetes Care, vol.161571, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01941507

H. Kadar, A multiplexed targeted assay for high-throughput quantitative analysis of serum methylamines by ultra performance liquid chromatography coupled to high resolution mass spectrometry, Arch. Biochem. Biophys, vol.597, pp.12-20, 2016.

M. Kaza, M. Kara?niewicz-?ada, K. Kosicka, A. Siemi?tkowska, and P. J. Rudzki, Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?, Journal of Pharmaceutical and Biomedical Analysis, vol.165, pp.381-385, 2019.

M. M. Moein, A. Beqqali, and M. Abdel-rehim, Bioanalytical method development and validation: Critical concepts and strategies, Journal of Chromatography B, vol.1043, pp.3-11, 2017.

R. E. Man, The Association of Estimated Glomerular Filtration Rate With Diabetic Retinopathy and Macular Edema, Investigative Opthalmology & Visual Science, vol.56, p.4810, 2015.

W. A. Teft, Identification and Characterization of Trimethylamine-N-oxide Uptake and Efflux Transporters, Mol. Pharm, vol.14, pp.310-318, 2017.

M. Maraninchi, Amélioration du profil lipidique après chirurgie bariatrique en relation avec une diminution des taux d'apolipoprotéine-CIII plasmatiques : redistribution entre lipoprotéines HDL et non-HDL, Nutrition Clinique et Métabolisme, vol.30, pp.259-260, 2016.

G. B. Goh, .. Schauer, P. R. Mccullough, and A. J. , Considerations for bariatric surgery in patients with cirrhosis, World J Gastroenterol, vol.24, pp.3112-3119, 2018.

B. Rennick, M. Acara, P. Hysert, and B. Mookerjee, Choline loss during hemodialysis: homeostatic control of plasma choline concentrations, Kidney Int, vol.10, pp.329-335, 1976.

R. Fernandez-prado, Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease, Nutrients, vol.9, 2017.

W. Mi, N. Van-wijk, M. Cansev, J. W. Sijben, and P. J. Kamphuis, Nutritional approaches in the risk reduction and management of Alzheimer's disease, Nutrition, vol.29, pp.1080-1089, 2013.

K. A. Guertin, Serum Trimethylamine N-oxide, Carnitine, Choline and Betaine in Relation to Colorectal Cancer Risk in the Alpha Tocopherol and Beta Carotene Study, Cancer Epidemiol Biomarkers Prev, vol.26, pp.945-952, 2017.

G. Guarnieri, Carnitine in maintenance hemodialysis patients, J Ren Nutr, vol.25, pp.169-175, 2015.

A. Steiber, J. Kerner, and C. L. Hoppel, Carnitine: a nutritional, biosynthetic, and functional perspective, Mol. Aspects Med, vol.25, pp.455-473, 2004.

M. D. Sanchez-niño and A. Ortiz, Differential effects of oral and intravenous l-carnitine on serum lipids: is the microbiota the answer?, Clin Kidney J, vol.7, pp.437-441, 2014.

M. A. Bain, R. Faull, G. Fornasini, R. W. Milne, and A. M. Evans, Accumulation of trimethylamine and trimethylamine-N -oxide in end-stage renal disease patients undergoing haemodialysis, Nephrol Dial Transplant, vol.21, pp.1300-1304, 2006.

A. Wilson, C. Mclean, and R. B. Kim, Trimethylamine-N-oxide: a link between the gut microbiome, bile acid metabolism, and atherosclerosis, Curr. Opin. Lipidol, vol.27, pp.148-154, 2016.

R. B. Kim, Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events, Kidney Int, vol.89, pp.1144-1152, 2016.

M. Trøseid, Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery, Metab Syndr Relat Disord, vol.14, pp.197-201, 2016.

M. L. Erickson, Effects of Lifestyle Intervention on Plasma Trimethylamine N-Oxide in Obese Adults, Nutrients, vol.11, 2019.

B. M. Liao, S. A. Mcmanus, W. E. Hughes, and C. Schmitz-peiffer, Flavin-Containing Monooxygenase 3 Reduces Endoplasmic Reticulum Stress in Lipid-Treated Hepatocytes, Mol Endocrinol, vol.30, pp.417-428, 2016.

R. Spector, New Insight into the Dietary Cause of Atherosclerosis: Implications for Pharmacology, J Pharmacol Exp Ther, vol.358, pp.103-108, 2016.

J. Gault, Mass Spectrometry Reveals the Direct Action of a Chemical Chaperone, J. Phys. Chem. Lett, vol.9, pp.4082-4086, 2018.

Z. D. Fu and C. D. Klaassen, Short-term calorie restriction feminizes the mRNA profiles of drug metabolizing enzymes and transporters in livers of mice, Toxicol. Appl. Pharmacol, vol.274, pp.137-146, 2014.

W. J. Welch and C. R. Brown, Influence of molecular and chemical chaperones on protein folding, Cell Stress Chaperones, vol.1, pp.109-115, 1996.

G. S. Hotamisligil, Endoplasmic reticulum stress and the inflammatory basis of metabolic disease, Cell, vol.140, pp.900-917, 2010.

C. S. Achard and D. R. Laybutt, Lipid-induced endoplasmic reticulum stress in liver cells results in two distinct outcomes: adaptation with enhanced insulin signaling or insulin resistance, Endocrinology, vol.153, pp.2164-2177, 2012.

F. Seyfried and M. K. Hankir, Could de-stressing the brain be the solution for long-term weight loss?, Cell Stress, vol.3, pp.29-37

Y. Heianza, W. Ma, J. E. Manson, K. M. Rexrode, and L. Qi, Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies, J Am Heart Assoc, vol.6, 2017.

L. Castillo, Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets, Proc Natl Acad Sci U S A, vol.90, pp.7749-7753, 1993.

T. D. Allerton, l-Citrulline Supplementation: Impact on Cardiometabolic Health, Nutrients, vol.10, 2018.

F. Palm, M. L. Onozato, Z. Luo, and C. S. Wilcox, Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems, Am. J. Physiol. Heart Circ. Physiol, vol.293, pp.3227-3245, 2007.

F. Mihout, Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-?1 synthesis, The Journal of Pathology, vol.223, pp.37-45, 2011.

D. Wang, Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease, Am. J. Kidney Dis, vol.51, pp.184-191, 2008.

C. Jahansouz, Partitioning of Adipose Lipid Metabolism by Altered Expression and Function of PPAR Isoforms After Bariatric Surgery, Int J Obes (Lond), vol.42, pp.139-146, 2018.

J. G. Cash, Therapeutic reduction of lysophospholipids in the digestive tract recapitulates the metabolic benefits of bariatric surgery and promotes diabetes remission, Molecular Metabolism, vol.16, pp.55-64, 2018.

Y. C. Luiking, G. A. Ten-have, R. R. Wolfe, and N. E. Deutz, Arginine de novo and nitric oxide production in disease states, Am J Physiol Endocrinol Metab, vol.303, pp.1177-1189, 2012.

M. Patil, J. Bhaumik, S. Babykutty, U. Banerjee, and D. Fukumura, Arginine dependence of tumor cells: targeting a chink in cancer's armor, Oncogene, vol.35, pp.4957-4972, 2016.

S. M. Morris, Recent advances in arginine metabolism, Curr Opin Clin Nutr Metab Care, vol.7, pp.45-51, 2004.

M. T. Gewaltig and G. Kojda, Vasoprotection by nitric oxide: mechanisms and therapeutic potential, Cardiovasc. Res, vol.55, pp.250-260, 2002.

G. Borrel, Genomics and metagenomics of trimethylamine-utilizing Archaea in the human gut microbiome, ISME J, vol.11, pp.2059-2074, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01658467

K. A. Romano, E. I. Vivas, D. Amador-noguez, and F. E. Rey, Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide, 2015.

J. Brugère, Archaebiotics. Gut Microbes, vol.5, pp.5-10, 2014.